MedPath

湖北福人福通药业有限公司

Ownership
-
Established
2016-11-24
Employees
-
Market Cap
-
Website
http://www.pegomould.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

8

NMPA:8

Drug Approvals

Tetracaine Hydrochloride Gel

Product Name
盐酸丁卡因凝胶
Approval Number
国药准字H20123292
Approval Date
Aug 2, 2022
NMPA

金银花口服液

Approval Number
国药准字Z20113081
Approval Date
Sep 7, 2021
NMPA

疮疡膏

Approval Number
国药准字Z42020137
Approval Date
Aug 12, 2021
NMPA

Danazol Soft Capsules

Product Name
宫福伊康
Approval Number
国药准字H20060604
Approval Date
Jul 29, 2021
NMPA

Gemfibrozil Capsules

Product Name
吉非罗齐胶囊
Approval Number
国药准字H20055225
Approval Date
Jun 15, 2021
NMPA

Indapamide Sustained-release Tablets

Product Name
吲达帕胺缓释片
Approval Number
国药准字H20052001
Approval Date
Aug 28, 2020
NMPA

金药膏

Approval Number
国药准字Z20020105
Approval Date
Aug 20, 2020
NMPA

智杞颗粒

Approval Number
国药准字B20050026
Approval Date
Aug 20, 2020
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.